News Image

Looking for growth without the hefty price tag? Consider NASDAQ:HALO.

By Mill Chart

Last update: Aug 8, 2024

Here's HALOZYME THERAPEUTICS INC (NASDAQ:HALO) for you, a growth stock our stock screener believes is undervalued. NASDAQ:HALO is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.


Affordable growth stocks image

Growth Assessment of NASDAQ:HALO

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:HALO, the assigned 9 reflects its growth potential:

  • The Earnings Per Share has grown by an impressive 34.57% over the past year.
  • Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.64% on average per year.
  • Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 25.63%.
  • Measured over the past years, HALO shows a very strong growth in Revenue. The Revenue has been growing by 40.42% on average per year.
  • The Earnings Per Share is expected to grow by 25.47% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 15.95% on average over the next years. This is quite good.

Evaluating Valuation: NASDAQ:HALO

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:HALO has achieved a 8 out of 10:

  • HALO's Price/Earnings ratio is rather cheap when compared to the industry. HALO is cheaper than 97.74% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.36. HALO is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 10.74 indicates a reasonable valuation of HALO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 97.56% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of HALO to the average of the S&P500 Index (20.01), we can say HALO is valued slightly cheaper.
  • Based on the Enterprise Value to EBITDA ratio, HALO is valued cheaply inside the industry as 95.99% of the companies are valued more expensively.
  • HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 98.78% of the companies in the same industry.
  • HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HALO has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as HALO's earnings are expected to grow with 32.64% in the coming years.

What does the Health looks like for NASDAQ:HALO

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:HALO, the assigned 7 for health provides valuable insights:

  • An Altman-Z score of 4.25 indicates that HALO is not in any danger for bankruptcy at the moment.
  • HALO has a better Altman-Z score (4.25) than 78.22% of its industry peers.
  • The Debt to FCF ratio of HALO is 3.54, which is a good value as it means it would take HALO, 3.54 years of fcf income to pay off all of its debts.
  • HALO's Debt to FCF ratio of 3.54 is amongst the best of the industry. HALO outperforms 96.52% of its industry peers.
  • HALO has a Current Ratio of 6.64. This indicates that HALO is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 6.64, HALO is doing good in the industry, outperforming 63.24% of the companies in the same industry.
  • HALO has a Quick Ratio of 5.36. This indicates that HALO is financially healthy and has no problem in meeting its short term obligations.

Analyzing Profitability Metrics

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:HALO has earned a 7 out of 10:

  • Looking at the Return On Assets, with a value of 17.31%, HALO belongs to the top of the industry, outperforming 99.30% of the companies in the same industry.
  • With an excellent Return On Equity value of 179.30%, HALO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 18.09%, HALO belongs to the top of the industry, outperforming 98.43% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 14.04%.
  • The 3 year average ROIC (17.78%) for HALO is below the current ROIC(18.09%), indicating increased profibility in the last year.
  • The Profit Margin of HALO (36.95%) is better than 98.95% of its industry peers.
  • The Operating Margin of HALO (44.25%) is better than 99.48% of its industry peers.
  • HALO has a Gross Margin of 78.51%. This is amongst the best in the industry. HALO outperforms 86.59% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of HALO

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (12/20/2024, 8:16:09 PM)

After market: 46.96 0 (0%)

46.96

-0.36 (-0.76%)

Follow us for more